Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today...

Flotek Industries, Inc. (NYSE: FTK) ("Flotek" or the "Company") has published a new investor presentation, which Chief Executive Officer, President & Chairman of the Board John W. Chisholm will...

Danielle Putnam, president of The New Flat Rate, is presenting at Service Roundtable's International Roundtable conference on April 18 in Orlando. Putnam's presentation, titled "The Executive Ride...

Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, Ph.D., Chairman,...

Enzyvant today announced that its investigational regenerative treatment (RVT-802) in late-stage development for congenital athymia will be featured during a platform presentation, at a symposium,...